|Videos|February 19, 2022

Study defines selection criteria for germline testing in UTUC

“I think, in general, patients with hereditary upper tract cancer may be under-recognized and under-referred for genetic evaluation,” says Hong Truong, MD.

In this video, Hong Truong, MD, discusses the background and methods of the study, “Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management,” which was presented at the 2022 ASCO Genitourinary Cancers Symposium. Truong is a urologic oncology fellow at Memorial Sloan Kettering Cancer Center in New York, New York.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more